1.All patients developed decompensated liver disease despite one patient having had a prior liver biopsy showing absence of cirrhosis.
所有的病人发展为失代偿性肝病，尽管其中一位经肝活检证实没有形成肝硬化。
2.Histologic examination of a liver biopsy specimen is regarded as the reference standard for detecting liver fibrosis.
肝活检的标本的组织学检查是检测肝纤维化的参照标准。
3.However, a liver biopsy cannot be performed in all patients with nonalcoholic fatty liver disease (NAFLD).
但是，不可能对所有的非酒精性脂肪性肝病（NAFLD）患者进行肝穿刺检查。
4.Liver biopsy is the gold standard for diagnosis of liver fibrosis, but it has limitations.
肝活组织检查是诊断肝纤维化的金标准，但有局限性；
5.Results The partial hepatectomy was performed in all patients except for one case of liver biopsy.
结果除1例行肝活检外，其余均手术完整切除病灶。
6.Prospective randomized trial of post-liver biopsy recovery positions: Does positioning really matter?
肝活检后复原的体位的前瞻性随机试验：体位真的重要吗？。
7.Liver biopsy showed major portal infiltration with monomorphic little lymphocytes.
肝活检显示主要门户浸润淋巴细胞与单很少。
8.With a PNFI cutoff point of 9 or more, liver fibrosis could be diagnosed without performing liver biopsy.
简约拟合指数截止点是9或者更多，这类人经过肝穿检测，就是肝纤维化。
9.We suggest that clinical suspicion of PH1 be pursued with a diagnostic liver biopsy.
我们建议临床上怀疑PH1继续下去，诊断肝活检。
10.Hepatology Digest: Liver biopsy is the gold standard for diagnosis of liver cirrhosis.
《国际肝病》：肝活检是肝硬化诊断的金标准。